These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3146324)

  • 1. Experience over 17 years with antioxidant treatment in Spielmeyer-Sjögren disease.
    Santavuori P; Heiskala H; Westermarck T; Sainio K; Moren R
    Am J Med Genet Suppl; 1988; 5():265-74. PubMed ID: 3146324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant treatment in Spielmeyer-Sjögren's disease.
    Santavuori P; Westermarck T; Rapola J; Pohja P; Moren R; Lappi M; Vuonnala U
    Acta Neurol Scand; 1985 Feb; 71(2):136-45. PubMed ID: 3984680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. English setter model and juvenile ceroid-lipofuscinosis in man.
    Koppang N
    Am J Med Genet; 1992 Feb; 42(4):599-604. PubMed ID: 1609842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antioxidative therapy in ceroid lipofuscinosis].
    Rotteveel JJ; Mullaart RA
    Tijdschr Kindergeneeskd; 1989 Oct; 57(5):181-6. PubMed ID: 2815055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenium treatment in neuronal ceroid-lipofuscinosis.
    Naidu S; Maumanee I; Olson J; Borel J; Moser H
    Am J Med Genet Suppl; 1988; 5():283-9. PubMed ID: 3146327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the clinical courses in patients with juvenile neuronal ceroid lipofuscinosis receiving antioxidant treatment and those without antioxidant treatment.
    Santavuori P; Heiskala H; Autti T; Johansson E; Westermarck T
    Adv Exp Med Biol; 1989; 266():273-82. PubMed ID: 2486154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant capacity in Fasciola hepatica patients before and after treatment with triclabendazole alone or in combination with ascorbic acid (vitamin C) and tocofersolan (vitamin E).
    Rehim WM; Sharaf IA; Hishmat M; el-Toukhy MA; Rawash NA; Fouad HN
    Arzneimittelforschung; 2003; 53(3):214-20. PubMed ID: 12705178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vitamin E and C supplements on antioxidant defense system in cardiovascular disease patients in Zahedan, southeast Iran.
    Karajibani M; Hashemi M; Montazerifar F; Dikshit M
    J Nutr Sci Vitaminol (Tokyo); 2010; 56(6):436-40. PubMed ID: 21422713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience of antioxidant treatment in neuronal ceroid-lipofuscinosis of Spielmeyer-Sjögren type.
    Santavuori P; Moren R
    Neuropadiatrie; 1977 Nov; 8(4):333-44. PubMed ID: 579434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charting the effects of antioxidant therapy in the diseased brain: focus on "vitamin E deficiency and metabolic deficits in neuronal ceroid lipofuscinosis described by bioinformatics".
    Järvelä I; Glueck SB
    Physiol Genomics; 2002 Dec; 11(3):183-4. PubMed ID: 12464692
    [No Abstract]   [Full Text] [Related]  

  • 11. Altered elemental profiles in neuronal ceroid lipofuscinosis.
    Johansson E; Lindh U; Westermarck T; Heiskala H; Santavuori P
    J Trace Elem Electrolytes Health Dis; 1990 Sep; 4(3):139-42. PubMed ID: 2136129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant supplementation attenuates oxidative stress in chronic hepatitis C patients.
    Farias MS; Budni P; Ribeiro CM; Parisotto EB; Santos CE; Dias JF; Dalmarco EM; Fröde TS; Pedrosa RC; Wilhelm Filho D
    Gastroenterol Hepatol; 2012; 35(6):386-94. PubMed ID: 22608494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C.
    Kennedy M; Bruninga K; Mutlu EA; Losurdo J; Choudhary S; Keshavarzian A
    Am J Gastroenterol; 2001 Apr; 96(4):1080-4. PubMed ID: 11316150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of the benefit of an antioxidant therapy in children and teenagers with Down syndrome.
    Parisotto EB; Giaretta AG; Zamoner A; Moreira EA; Fröde TS; Pedrosa RC; Filho DW
    Res Dev Disabil; 2015; 45-46():14-20. PubMed ID: 26207872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant supplementation for lung disease in cystic fibrosis.
    Ciofu O; Lykkesfeldt J
    Cochrane Database Syst Rev; 2014 Aug; (8):CD007020. PubMed ID: 25102015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant potential of vitamins A, E and C in modulating oxidative stress in rat brain.
    Zaidi SM; Banu N
    Clin Chim Acta; 2004 Feb; 340(1-2):229-33. PubMed ID: 14734217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective effect of antioxidants in experimental poisoning].
    Setko NP
    Gig Sanit; 1986 Feb; (2):16-8. PubMed ID: 3957046
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease.
    Kontush A; Mann U; Arlt S; Ujeyl A; Lührs C; Müller-Thomsen T; Beisiegel U
    Free Radic Biol Med; 2001 Aug; 31(3):345-54. PubMed ID: 11461772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of kidney damage by supplementation of vitamins C and E in rats with deoxycorticosterone-salt-induced hypertension.
    Seifi B; Kadkhodaee M; Karimian SM; Zahmatkesh M; Shams S; Bakhshi E
    Iran J Kidney Dis; 2009 Oct; 3(4):197-202. PubMed ID: 19841522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of omega-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: an open-label pilot study.
    Sivrioglu EY; Kirli S; Sipahioglu D; Gursoy B; Sarandöl E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1493-9. PubMed ID: 17688987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.